{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,17]],"date-time":"2026-08-17T21:53:31Z","timestamp":1787003611575,"version":"build-2736575974"},"reference-count":35,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,10,2]],"date-time":"2025-10-02T00:00:00Z","timestamp":1759363200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2025,10,2]],"date-time":"2025-10-02T00:00:00Z","timestamp":1759363200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Sci Rep"],"DOI":"10.1038\/s41598-025-16758-z","type":"journal-article","created":{"date-parts":[[2025,10,2]],"date-time":"2025-10-02T09:27:52Z","timestamp":1759397272000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":4,"title":["Comparative study of the chemical profile, cytotoxic activity, and molecular docking of Serenoa repens extract and a pharmaceutical product"],"prefix":"10.1038","volume":"15","author":[{"given":"Ehab M.","family":"Mostafa","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nasser M.","family":"Aldekhail","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Taghreed Stum","family":"Alnusaire","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shaimaa","family":"Hussein","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alaa M.","family":"Khedr","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mohammed A.","family":"AlAwadh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Samy","family":"Selim","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Haifa A. S.","family":"Alhaithloul","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Komla Mawunyo","family":"Dossouvi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ahmed","family":"Ismail","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,10,2]]},"reference":[{"key":"16758_CR1","doi-asserted-by":"publisher","first-page":"49","DOI":"10.1038\/nrurol.2012.192","volume":"10","author":"DD \u00d8rsted","year":"2013","unstructured":"\u00d8rsted, D. D. & Bojesen, S. E. The link between benign prostatic hyperplasia and prostate cancer. Nat. Reviews Urol. 10, 49\u201354 (2013).","journal-title":"Nat. Reviews Urol."},{"key":"16758_CR2","doi-asserted-by":"publisher","first-page":"257","DOI":"10.2174\/1389557514666140123124321","volume":"14","author":"S Aggarwal","year":"2014","unstructured":"Aggarwal, S. et al. An overview of phytotherapeutic approaches for the treatment of benign prostatic hyperplasia. Mini Rev. Med. Chem. 14, 257\u2013270 (2014).","journal-title":"Mini Rev. Med. Chem."},{"key":"16758_CR3","doi-asserted-by":"publisher","first-page":"e35540","DOI":"10.1097\/MD.0000000000035540","volume":"102","author":"J Xiang","year":"2023","unstructured":"Xiang, J., Li, Z. & Wang, C. Exploring the mechanism of action of Qian lie Xing Fang during the treatment of benign prostatic hyperplasia via network Pharmacology and molecular dynamics simulation analyses. Medicine 102, e35540 (2023).","journal-title":"Medicine"},{"key":"16758_CR4","doi-asserted-by":"publisher","first-page":"1394","DOI":"10.1002\/nau.24352","volume":"39","author":"Y Matsukawa","year":"2020","unstructured":"Matsukawa, Y. et al. Useful parameters to predict the presence of detrusor overactivity in male patients with lower urinary tract symptoms. Neurourol. Urodyn. 39, 1394\u20131400 (2020).","journal-title":"Neurourol. Urodyn."},{"key":"16758_CR5","doi-asserted-by":"publisher","first-page":"28","DOI":"10.1016\/j.ajur.2017.11.005","volume":"5","author":"EH Kim","year":"2018","unstructured":"Kim, E. H., Brockman, J. A. & Andriole, G. L. The use of 5-alpha reductase inhibitors in the treatment of benign prostatic hyperplasia. Asian J. Urol. 5, 28\u201332 (2018).","journal-title":"Asian J. Urol."},{"key":"16758_CR6","doi-asserted-by":"publisher","first-page":"21987","DOI":"10.1038\/s41598-024-69607-w","volume":"14","author":"HA Mohammed","year":"2024","unstructured":"Mohammed, H. A. et al. Phytochemical, biological, and computational investigations of ephedra Alata decne. Growing in salinity conditions of Arabian Peninsula. Sci. Rep. 14, 21987 (2024).","journal-title":"Sci. Rep."},{"key":"16758_CR7","first-page":"983","volume":"46","author":"H Mando","year":"2023","unstructured":"Mando, H., Hassan, A., Abo Chameh, G., Moussa, N. & QUALITY ASSESSMENT OF HERBAL MEDICINAL PRODUCTS IN BENIGN PROSTATE HYPERTROPHY. CHEMICAL MARKERS AND FINGERPRINT ANALYSIS. Bull. Pharm. Sci. Assiut Univ. 46, 983\u2013996 (2023).","journal-title":"Bull. Pharm. Sci. Assiut Univ."},{"key":"16758_CR8","doi-asserted-by":"publisher","first-page":"100153","DOI":"10.1016\/j.phyplu.2021.100153","volume":"2","author":"K Leisegang","year":"2022","unstructured":"Leisegang, K. et al. A systematic review of herbal medicine in the clinical treatment of benign prostatic hyperplasia. Phytomedicine Plus. 2, 100153 (2022).","journal-title":"Phytomedicine Plus"},{"key":"16758_CR9","doi-asserted-by":"publisher","first-page":"53","DOI":"10.1016\/S1570-0232(04)00676-2","volume":"812","author":"YZ Liang","year":"2004","unstructured":"Liang, Y. Z., Xie, P. & Chan, K. Quality control of herbal medicines. J. Chromatogr. B. 812, 53\u201370 (2004).","journal-title":"J. Chromatogr. B"},{"key":"16758_CR10","doi-asserted-by":"publisher","first-page":"199","DOI":"10.4081\/aiua.2018.3.199","volume":"90","author":"D Buonocore","year":"2018","unstructured":"Buonocore, D. et al. Serenoa repens extracts: in vitro study of the 5\u03b1-reductase activity in a co-culture model for benign prostatic hyperplasia. Archivio Italiano Di Urol. E Andrologia. 90, 199\u2013202 (2018).","journal-title":"Archivio Italiano Di Urol. E Andrologia"},{"key":"16758_CR11","doi-asserted-by":"publisher","first-page":"1046","DOI":"10.1016\/j.jpainsymman.2015.12.315","volume":"51","author":"GK Wyatt","year":"2016","unstructured":"Wyatt, G. K., Sikorskii, A., Safikhani, A., McVary, K. T. & Herman, J. Saw palmetto for symptom management during radiation therapy for prostate cancer. J. Pain Symptom Manag. 51, 1046\u20131054 (2016).","journal-title":"J. Pain Symptom Manag."},{"key":"16758_CR12","doi-asserted-by":"publisher","first-page":"776","DOI":"10.1016\/S0011-393X(05)80771-4","volume":"55","author":"J Braeckman","year":"1994","unstructured":"Braeckman, J. The extract of Serenoa repens in the treatment of benign prostatic hyperplasia: a multicenter open study. Curr. Therapeutic Res. 55, 776\u2013785 (1994).","journal-title":"Curr. Therapeutic Res."},{"key":"16758_CR13","doi-asserted-by":"publisher","first-page":"2208","DOI":"10.3390\/molecules24122208","volume":"24","author":"G Marti","year":"2019","unstructured":"Marti, G. et al. Comparison of the phytochemical composition of Serenoa repens extracts by a multiplexed metabolomic approach. Molecules 24, 2208 (2019).","journal-title":"Molecules"},{"key":"16758_CR14","first-page":"677","volume":"10","author":"K Rashid","year":"2020","unstructured":"Rashid, K., Raj, V., Kumar, P. & Nishad, K. Hair care promising herbs: A review. Pharm. Res. 10, 677\u2013688 (2020).","journal-title":"Pharm. Res."},{"key":"16758_CR15","doi-asserted-by":"crossref","unstructured":"Anastassakis, K. in Androgenetic Alopecia From A to Z: Vol. 2 Drugs, Herbs, Nutrition and Supplements 429\u2013439Springer, (2022).","DOI":"10.1007\/978-3-031-08057-9_49"},{"key":"16758_CR16","doi-asserted-by":"publisher","first-page":"709","DOI":"10.2217\/fon-2017-0561","volume":"14","author":"X Yin","year":"2018","unstructured":"Yin, X. et al. Identification of CDK2 as a novel target in treatment of prostate cancer. Future Oncol. 14, 709\u2013718 (2018).","journal-title":"Future Oncol."},{"key":"16758_CR17","first-page":"377","volume":"22","author":"Y Che","year":"2009","unstructured":"Che, Y., Hou, S., Kang, Z. & Lin, Q. Serenoa repens induces growth arrest and apoptosis of human multiple myeloma cells via inactivation of STAT 3 signaling. Oncol. Rep. 22, 377\u2013383 (2009).","journal-title":"Oncol. Rep."},{"key":"16758_CR18","first-page":"38","volume":"13","author":"A Ismail","year":"2020","unstructured":"Ismail, A. et al. Chemical composition and therapeutic potential of three Cycas species in brain damage and pancreatitis provoked by \u03b3-radiation exposure in rats. J. Radiation Res. Appl. Sci. 13, 38\u201352 (2020).","journal-title":"J. Radiation Res. Appl. Sci."},{"key":"16758_CR19","doi-asserted-by":"publisher","first-page":"2521","DOI":"10.3390\/plants11192521","volume":"11","author":"HY Aati","year":"2022","unstructured":"Aati, H. Y. et al. Garcinia cambogia phenolics as potent anti-COVID-19 agents: phytochemical profiling, biological activities, and molecular Docking. Plants 11, 2521 (2022).","journal-title":"Plants"},{"key":"16758_CR20","unstructured":"Riss, T. L. et al. Cell viability assays. Assay guidance manual [Internet] (2016)."},{"key":"16758_CR21","doi-asserted-by":"publisher","first-page":"15","DOI":"10.1007\/BF01404408","volume":"11","author":"JM Edmondson","year":"1988","unstructured":"Edmondson, J. M., Armstrong, L. S. & Martinez, A. O. A rapid and simple MTT-based spectrophotometric assay for determining drug sensitivity in monolayer cultures. J. Tissue Cult. Methods. 11, 15\u201317 (1988).","journal-title":"J. Tissue Cult. Methods"},{"key":"16758_CR22","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/s12943-018-0804-2","volume":"17","author":"KS Bhullar","year":"2018","unstructured":"Bhullar, K. S. et al. Kinase-targeted cancer therapies: progress, challenges and future directions. Mol. Cancer. 17, 1\u201320 (2018).","journal-title":"Mol. Cancer"},{"key":"16758_CR23","doi-asserted-by":"publisher","first-page":"2128","DOI":"10.1002\/cbic.201200316","volume":"13","author":"M Martin","year":"2012","unstructured":"Martin, M. et al. A novel approach to the discovery of small-molecule ligands of CDK2. Chembiochem 13, 2128\u20132136 (2012).","journal-title":"Chembiochem"},{"key":"16758_CR24","doi-asserted-by":"publisher","first-page":"87","DOI":"10.1016\/j.jtbi.2013.05.014","volume":"334","author":"SK Tripathi","year":"2013","unstructured":"Tripathi, S. K., Muttineni, R. & Singh, S. K. Extra precision docking, free energy calculation and molecular dynamics simulation studies of CDK2 inhibitors. J. Theor. Biol. 334, 87\u2013100 (2013).","journal-title":"J. Theor. Biol."},{"key":"16758_CR25","doi-asserted-by":"publisher","first-page":"57","DOI":"10.2174\/1573409916666191231113055","volume":"17","author":"SS Kim","year":"2021","unstructured":"Kim, S. S., Alves, M. J., Gygli, P., Otero, J. & Lindert, S. Identification of novel Cyclin A2 binding site and nanomolar inhibitors of Cyclin A2-CDK2 complex. Curr. Comput.-Aided Drug Design. 17, 57\u201368 (2021).","journal-title":"Curr. Comput.-Aided Drug Design"},{"key":"16758_CR26","doi-asserted-by":"publisher","first-page":"2110","DOI":"10.1002\/qua.24481","volume":"113","author":"AD Bochevarov","year":"2013","unstructured":"Bochevarov, A. D. et al. Jaguar: A high-performance quantum chemistry software program with strengths in life and materials sciences. Int. J. Quantum Chem. 113, 2110\u20132142 (2013).","journal-title":"Int. J. Quantum Chem."},{"key":"16758_CR27","doi-asserted-by":"publisher","first-page":"209","DOI":"10.1007\/s40005-023-00647-6","volume":"54","author":"N Veronica","year":"2024","unstructured":"Veronica, N., Loh, Y. Y., Loh, L. X. Y., Heng, P. W. S. & Liew, C. V. Impact of magnesium stearate physical and chemical variabilities on pharmaceutical powder flow and tablet physical properties. J. Pharm. Invest. 54, 209\u2013227 (2024).","journal-title":"J. Pharm. Invest."},{"key":"16758_CR28","unstructured":"Publishing, W. A. Pharmaceutical Manufacturing EncyclopediaVol. 1 (Elsevier, 2007)."},{"key":"16758_CR29","unstructured":"Food, U. & Administration, D."},{"key":"16758_CR30","doi-asserted-by":"publisher","first-page":"733","DOI":"10.1016\/j.drudis.2010.07.003","volume":"15","author":"SK Kota","year":"2010","unstructured":"Kota, S. K. & Balasubramanian, S. Cancer therapy via modulation of micro RNA levels: a promising future. Drug Discovery Today. 15, 733\u2013740 (2010).","journal-title":"Drug Discovery Today"},{"key":"16758_CR31","doi-asserted-by":"publisher","first-page":"27","DOI":"10.1016\/0378-8741(92)90057-X","volume":"36","author":"L Chang-Xiao","year":"1992","unstructured":"Chang-Xiao, L. & Pei-Gen, X. Recent advances on ginseng research in China. J. Ethnopharmacol. 36, 27\u201338 (1992).","journal-title":"J. Ethnopharmacol."},{"key":"16758_CR32","doi-asserted-by":"publisher","first-page":"105103","DOI":"10.1016\/j.arabjc.2023.105103","volume":"16","author":"HA Mohammed","year":"2023","unstructured":"Mohammed, H. A. et al. Variability in the volatile constituents and biological activities of Achillea millefolium L. essential oils obtained from different plant parts and by different solvents. Arab. J. Chem. 16, 105103 (2023).","journal-title":"Arab. J. Chem."},{"key":"16758_CR33","doi-asserted-by":"publisher","first-page":"90","DOI":"10.5530\/fra.2015.2.7","volume":"5","author":"NA Panat","year":"2015","unstructured":"Panat, N. A. et al. Antioxidant profiling of C3 Quercetin glycosides: quercitrin, Quercetin 3-\u03b2-D-glucoside and Quercetin 3-O-(6-O-malonyl)-\u03b2-Dglucoside in cell free environment. Free Radicals Antioxid. 5, 90\u2013100 (2015).","journal-title":"Free Radicals Antioxid."},{"key":"16758_CR34","doi-asserted-by":"publisher","first-page":"258","DOI":"10.3390\/antiox12020258","volume":"12","author":"J Terao","year":"2023","unstructured":"Terao, J. Potential role of Quercetin glycosides as anti-atherosclerotic food-derived factors for human health. Antioxidants 12, 258 (2023).","journal-title":"Antioxidants"},{"key":"16758_CR35","doi-asserted-by":"publisher","first-page":"774","DOI":"10.3390\/cancers17050774","volume":"17","author":"M Siskin","year":"2025","unstructured":"Siskin, M., Economides, M. P. & Wise, D. R. Cyclin-Dependent kinase Inhibition in prostate cancer: past, present, and future. Cancers 17, 774 (2025).","journal-title":"Cancers"}],"container-title":["Scientific Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41598-025-16758-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-025-16758-z","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-025-16758-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,6]],"date-time":"2025-10-06T22:02:53Z","timestamp":1759788173000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41598-025-16758-z"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,10,2]]},"references-count":35,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["16758"],"URL":"https:\/\/doi.org\/10.1038\/s41598-025-16758-z","relation":{},"ISSN":["2045-2322"],"issn-type":[{"value":"2045-2322","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,10,2]]},"assertion":[{"value":"15 March 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"19 August 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"2 October 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no competing interests.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}},{"value":"The authors declare no conflict of interest.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}}],"article-number":"34338"}}